Trade Adaptive Biotechnologies Corporation - ADPT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.49 |
| Open | 6.59 |
| 1-Year Change | 35.6% |
| Day's Range | 6.38 - 6.72 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 17, 2024 | 6.49 | -0.26 | -3.85% | 6.75 | 6.90 | 6.37 |
| Dec 16, 2024 | 6.75 | 0.63 | 10.29% | 6.12 | 6.76 | 6.09 |
| Dec 13, 2024 | 6.27 | 0.21 | 3.47% | 6.06 | 6.35 | 5.95 |
| Dec 12, 2024 | 6.13 | -0.02 | -0.33% | 6.15 | 6.33 | 6.03 |
| Dec 11, 2024 | 6.35 | -0.17 | -2.61% | 6.52 | 6.73 | 6.35 |
| Dec 10, 2024 | 6.68 | 0.39 | 6.20% | 6.29 | 7.04 | 6.21 |
| Dec 9, 2024 | 6.41 | 0.14 | 2.23% | 6.27 | 6.67 | 6.26 |
| Dec 6, 2024 | 6.22 | 0.24 | 4.01% | 5.98 | 6.34 | 5.96 |
| Dec 5, 2024 | 6.05 | 0.07 | 1.17% | 5.98 | 6.19 | 5.91 |
| Dec 4, 2024 | 6.11 | -0.09 | -1.45% | 6.20 | 6.43 | 6.07 |
| Dec 3, 2024 | 6.27 | -0.20 | -3.09% | 6.47 | 6.52 | 6.14 |
| Dec 2, 2024 | 6.49 | 0.61 | 10.37% | 5.88 | 6.56 | 5.83 |
| Nov 29, 2024 | 5.92 | 0.22 | 3.86% | 5.70 | 5.98 | 5.66 |
| Nov 27, 2024 | 5.71 | 0.09 | 1.60% | 5.62 | 5.82 | 5.50 |
| Nov 26, 2024 | 5.64 | 0.04 | 0.71% | 5.60 | 5.91 | 5.28 |
| Nov 25, 2024 | 5.56 | 0.85 | 18.05% | 4.71 | 5.77 | 4.71 |
| Nov 22, 2024 | 4.64 | 0.36 | 8.41% | 4.28 | 4.68 | 4.27 |
| Nov 21, 2024 | 4.35 | 0.01 | 0.23% | 4.34 | 4.47 | 4.25 |
| Nov 20, 2024 | 4.40 | 0.06 | 1.38% | 4.34 | 4.55 | 4.30 |
| Nov 19, 2024 | 4.46 | 0.04 | 0.90% | 4.42 | 4.62 | 4.36 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Adaptive Biotechnologies Corporation Company profile
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Adaptive Biotechnologies Corp revenues increased 57% to $154.3M. Net loss increased 42% to $207.3M. Revenues reflect Sequencing revenue segment increase of 90% to $78.9M, Development revenue segment increase of 32% to $75.4M. Higher net loss reflects Research and development - Balancing increase of 19% to $128.3M (expense), General and administrative - Balancing increase of 47% to $59.7M (expense).
| Industry: | Bio Diagnostics & Testing |
1165 Eastlake Ave E
SEATTLE
WASHINGTON 98109
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com